Heartland Advisors Inc. Sells 26,644 Shares of Envista Holdings Corporation $NVST

Heartland Advisors Inc. lessened its position in shares of Envista Holdings Corporation (NYSE:NVST) by 6.2% in the first quarter, according to its most recent filing with the SEC. The firm owned 402,353 shares of the company’s stock after selling 26,644 shares during the quarter. Heartland Advisors Inc.’s holdings in Envista were worth $10,208,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd grew its stake in Envista by 16,711.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after purchasing an additional 1,504 shares during the period. Allworth Financial LP lifted its stake in Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after buying an additional 776 shares during the period. UMB Bank n.a. boosted its holdings in shares of Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after buying an additional 636 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after buying an additional 949 shares during the period. Finally, IFP Advisors Inc lifted its position in shares of Envista by 102.9% during the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after acquiring an additional 1,071 shares during the period.

Envista Price Performance

Envista stock opened at $26.73 on Friday. The stock has a market cap of $4.35 billion, a P/E ratio of 65.18, a P/E/G ratio of 1.52 and a beta of 0.86. The company has a quick ratio of 2.06, a current ratio of 2.44 and a debt-to-equity ratio of 0.47. The company’s 50 day moving average price is $24.93 and its two-hundred day moving average price is $25.58. Envista Holdings Corporation has a 52 week low of $18.77 and a 52 week high of $30.42.

Envista (NYSE:NVST) last released its earnings results on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The company had revenue of $705.50 million for the quarter, compared to analysts’ expectations of $680.03 million. Envista had a return on equity of 7.11% and a net margin of 2.41%.The business’s revenue for the quarter was up 14.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, equities analysts predict that Envista Holdings Corporation will post 1.42 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have commented on NVST. Zacks Research cut shares of Envista from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. Citigroup initiated coverage on shares of Envista in a report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 price objective on the stock. Barclays reduced their target price on Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday, June 11th. Wall Street Zen lowered Envista from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Finally, Weiss Ratings downgraded Envista from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Six investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. Based on data from MarketBeat, Envista currently has an average rating of “Hold” and an average price target of $28.54.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.